NEWS
CKBA, an innovative drug of Taienkang, launched the Phase II clinical trials.
Release time：
2023-11-21
On Nov. 17th, 2023, the press conference on the Phase II Clinical Trial Protocol of Innovative Drug and the China Diagnosis and Treatment Consensus Seminar for the Treatment of Vitiligo Disease were held in Shanghai. At the meeting, Taienkang officiallly announced the launch of its CKBA vitiligo drug phase II clinical trial. The day before this day, a Taienkang's subsidiary company, BCY pharm, just completed the first examinee (the patient) enrollment for the Phase II clinical trial for the Class I innovative drug-CKBA (Saccinic Acid) ointment for the treatment of vitiligo.
Hot news
Scan QR code for mobile view
TEL.
ADD.
Manufacturing Site Address:
No. 22, Jiankang Road,
Economic Development Zone,
Yuechi County 638300,
Sichuan Province,
China.